| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |